Atherosclerosis licenses for an exceeding immune response in COVID-19 disease by interferon priming in circulating myeloid cells. - Leberzammer J; Abplanalp WT; Grikscheit K; Solomonidis EG; Glaser SF; Schuhmacher B; Merten M; Jeremijev G; Wilken-Schmitz A; Korth L; John D; Günther S; et al. (Cardiovascular research, 2026)